Literature DB >> 1833349

Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies.

C M van Duijn1, D Clayton, V Chandra, L Fratiglioni, A B Graves, A Heyman, A F Jorm, E Kokmen, K Kondo, J A Mortimer, W A Rocca, S L Shalat, H Soininen, A Hofman.   

Abstract

Case-control studies of Alzheimer's disease were re-analysed to examine the association of Alzheimer's disease with family history in first degree relatives of dementia, Down's syndrome and Parkinson's disease. Overall, the relative risk of Alzheimer's disease for those with at least one first degree relative with dementia was 3.5 (95% confidence interval 2.6-4.6). Stratification according to age of onset of Alzheimer's disease showed that the relative risk decreased with increasing onset age. However, among patients with an onset of disease after 80 years, there were still significantly more subjects with one or more first degree relatives with dementia as compared to controls (relative risk 2.6; 95% confidence interval 1.3-5.2). The relative risk of Alzheimer's disease was significantly lower in patients who had one first degree relative with dementia (relative risk 2.6; 95% confidence interval 2.0-3.5) as compared to those who had two or more affected relatives (relative risk 7.5; 95% confidence interval 3.3-16.7). Furthermore, the re-analysis showed a significant association between Alzheimer's disease and family history of Down's syndrome (relative risk 2.7; 95% confidence interval 1.2-5.7), which was strongest in those patients who had a positive family history of dementia. The relative risk of Alzheimer's disease for those with a positive family history of Parkinson's disease was 2.4 (95% confidence interval 1.0-5.8).

Entities:  

Mesh:

Year:  1991        PMID: 1833349     DOI: 10.1093/ije/20.supplement_2.s13

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  34 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

2.  Familial risk for Alzheimer's disease alters fMRI activation patterns.

Authors:  Susan Spear Bassett; David M Yousem; Catherine Cristinzio; Ivana Kusevic; Michael A Yassa; Brian S Caffo; Scott L Zeger
Journal:  Brain       Date:  2006-05       Impact factor: 13.501

Review 3.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

4.  Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease.

Authors:  A B Graves; D Rosner; D Echeverria; J A Mortimer; E B Larson
Journal:  Occup Environ Med       Date:  1998-09       Impact factor: 4.402

Review 5.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

6.  Family-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing data.

Authors:  M Saad; Z Brkanac; E M Wijsman
Journal:  Genes Brain Behav       Date:  2015-09-23       Impact factor: 3.449

7.  Effects of the apolipoprotein E ε4 allele on functional MRI during n-back working memory tasks in healthy middle-aged adults.

Authors:  C-J Chen; C-C Chen; D Wu; N-F Chi; P-C Chen; Y-P Liao; H-W Chiu; C-J Hu
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

Review 8.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

9.  Chromosome 14 and late-onset familial Alzheimer disease (FAD).

Authors:  G D Schellenberg; H Payami; E M Wijsman; H T Orr; K A Goddard; L Anderson; E Nemens; J A White; M E Alonso; M J Ball
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

10.  The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.

Authors:  C E Yu; H Payami; J M Olson; M Boehnke; E M Wijsman; H T Orr; W A Kukull; K A Goddard; E Nemens; J A White
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.